Toxicogenomics

Toxicogenomics is defined as the study of the structure and function of the genome and its responds to adverse xenobiotic exposure. It is the toxicological subdiscipline of pharmacogenomics, which is broadly defined as the study of inter-individual variations in whole-genome or candidate gene single-nucleotide polymorphism maps, haplotype markers, and alterations in gene expression that might correlate with drug responses.

  • Toxicogenomics in regulatory application
  • SAR/QSAR models
  • Screening tools to predict toxicity & targets
  • Signature/biomarker qualification
  • Bioinformatics and interpretive challenges in toxicogenomics
  • Challenges of conventional toxicology approaches
  • Toxicogenomics as a predictive tool
  • Identifying critical targets or pathways
  • Gene cloning
  • Use of toxicogenomics information directly as a POD

Related Conference of Toxicogenomics

January 28-29, 2019

Global Summit on Toxicology and Forensic Science

Osaka, Japan
January 30-31, 2019

19th Annual Conference on Inhalation Toxicology

Abu Dhabi. UAE
May 06-07, 2019

20th World Congress on Toxicology and Pharmacology

Radisson Hotel Narita, Tokyo, Japan
September 18-19, 2019

20th world Conference on Environmental Toxicology and Pharmacology

Radisson Hotel Narita, Tokyo, Japan

Toxicogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in